Trial · NCT07910695
Feasibility Study of a Relaxation and Guided Imagery Intervention Research Protocol for Use in School Settings.
NCT07910695, Not applicable, Not yet recruiting, Pace University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Feasibility Study of a Relaxation and Guided Imagery Intervention Research Protocol for Use in School Settings. Trials, record NCT07910695. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910695
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Feasibility Study of a Relaxation and Guided Imagery Intervention Research Protocol for Use in School Settings.
- NCT number
- NCT07910695
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 255 participants, estimated
- Lead sponsor
- Pace University
- Conditions
- Feasibility Studies, Acceptability, Pilot Study
- Interventions
- Relaxation and Guided Imagery, Progressive Muscle Relaxation
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participants' perceptions of intervention feasibility and acceptability | At intervention completion, an average of 3 months. | Proportion of participants reporting favorable feasibility and acceptability ratings relative to implementing an intervention in a school setting with K-12 students. Reporting outcomes of the Usage Rating Profile - Intervention Acceptability Scale (min score = 9, max score = 54) and Feasibility Scale (min score = 6, max score = 36) |
| Primary | Participants' perceptions of assessment procedure feasibility and acceptability | At intervention completion, an average of 3 months. | Proportion of participants reporting favorable feasibility and acceptability ratings relative to implementation of data collection procedures in school settings. Reporting outcomes of the Usage Rating Profile - Assessment Acceptability Scale (min score = 9, max score = 54) and Feasibility Scale (min score = 6, max score = 36) |
| Primary | Child participants' perceptions of intervention feasibility and acceptability | At intervention completion, an average of 3 months. | Proportion of participants reporting favorable feasibility ratings relative to using an intervention in school settings. Reporting outcomes of the Children's Usage Rating Profile Feasibility Scale (min score = 7, max score = 42). |
| Primary | Researcher Developed Qualitative Feedback Questionnaire for Educational Personnel | At intervention completion, an average of 3 months. | Semantic themes in educational personnel's satisfaction with research procedures and feedback for improvement. Reporting outcomes of qualitative data (thematic analysis). |
| Primary | Researcher Developed Qualitative Feedback Questionnaire for Students | At intervention completion, an average of 3 months. | Semantic themes in students' satisfaction with research procedures and feedback for improvement. Reporting outcomes of qualitative data (thematic analysis). |
| Other | Intervention Efficacy Outcome Measure | Day 1 and at intervention completion, an average of 3 months. | RGI intervention efficacy from baseline to post-test. The specific measure will be identified as part of the major adaptation to the intervention and related study protocol occurring in Study 1. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910695
GET https://conductscience.org/api/trials/v1/NCT07910695/registered